Iqvia vs Medpace: revenue, profit, margins and growth compared
Iqvia brought in $16.3B of revenue in fiscal 2025, Medpace $2.5B in fiscal 2025. Revenue changed by +5.9% at Iqvia and +20.0% at Medpace on the year before, so Medpace grew faster. Iqvia kept 8.3% of its revenue as net profit, Medpace 17.8%. Free cash flow was $2.1B at Iqvia and $681.9M at Medpace.
Fiscal years as each company reports them; the two may end in different months.
Questions about Iqvia and Medpace
Which is bigger by revenue, Iqvia or Medpace?
Iqvia is bigger by revenue: $16.3B in fiscal 2025, against $2.5B for Medpace in fiscal 2025.
Which keeps more of its revenue as profit, Iqvia or Medpace?
Iqvia had a net margin of 8.3% in fiscal 2025; Medpace had 17.8% in fiscal 2025.
Which grew revenue faster, Iqvia or Medpace?
In their latest fiscal years revenue changed by +5.9% at Iqvia and +20.0% at Medpace.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.